SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-024169
Filing Date
2024-02-05
Accepted
2024-02-05 17:10:04
Documents
22
Period of Report
2024-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d733695d8k.htm   iXBRL 8-K 40946
2 EX-4.1 d733695dex41.htm EX-4.1 81864
3 EX-4.2 d733695dex42.htm EX-4.2 88960
4 EX-4.3 d733695dex43.htm EX-4.3 88428
5 EX-5.1 d733695dex51.htm EX-5.1 12941
6 EX-10.1 d733695dex101.htm EX-10.1 214836
7 EX-99.1 d733695dex991.htm EX-99.1 11351
11 GRAPHIC g733695g0205000034895.jpg GRAPHIC 4738
12 GRAPHIC g733695g0205094027108.jpg GRAPHIC 2637
  Complete submission text file 0001193125-24-024169.txt   820302

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA nexi-20240202.xsd EX-101.SCH 2825
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20240202_lab.xml EX-101.LAB 17977
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20240202_pre.xml EX-101.PRE 11241
23 EXTRACTED XBRL INSTANCE DOCUMENT d733695d8k_htm.xml XML 3626
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 24596730
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)